Why gold’s 50% gain isn’t what it seems? As financial media fixates on flashy sectors and speculative headlines, gold is riding a quieter but deeper wave. Our A.I. highlights where these historic flows are going next: safe-asset demand, fiscal strain, and currency risk all affect not just gold’s future direction, but an even bigger surprise. We’re hosting a free live training session to walk you through these signals and show you how to follow smart, real-time cues (and not the hype). Join the live A.I. forecast and get ahead of the crowd. |
|
|
Top Earnings NewsPalantir Technologies Beat Expectations Palantir Technologies (PLTR) reported earnings of $0.21 per share on revenue of $1.18 billion for the third quarter ended September 2025. The consensus earnings estimate was $0.17 per share on revenue of $1.09 billion. The Earnings Whisper number was $0.19 per share. The company beat expectations by 10.53% while revenue grew 62.79% on a year-over-year basis.
The company said it expects 2025 revenue of $4.396 billion to $4.400 billion. The company's previous guidance was revenue of $4.142 billion to $4.150 billion, and the current consensus revenue estimate is $4.17 billion for the year ending December 31, 2025.
“114% - our Rule of 40 score! These results make undeniable the transformational impact of using AIP to compound AI leverage. Year-over-year growth in our U.S. business surged to 77%, and year-over-year growth in U.S. commercial climbed to 121%. We are yet again announcing the highest sequential quarterly revenue growth guide in our company’s history, representing 61% year-over-year growth,” said Alex C. Karp, Co-Founder and Chief Executive Officer of Palantir Technologies.
Palantir Technologies Inc. is a software company that builds enterprise data platforms for use by organizations with complex and sensitive data environments.
|
Positive SurpriseTG Therapeutics Beat Expectations TG Therapeutics (TGTX) reported earnings of $2.43 per share on revenue of $161.71 million for the third quarter ended September 2025. The consensus earnings estimate was $0.24 per share on revenue of $150.66 million. The Earnings Whisper number was $0.28 per share. The company beat expectations by 767.86% while revenue grew 92.79% on a year-over-year basis.
The company said it expects 2025 revenue of approximately $600.0 million. The company's previous guidance was revenue of approximately $585.0 million, and the current consensus revenue estimate is $581.57 million for the year ending December 31, 2025.
TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases.
View All Earnings
Negative SurpriseMedifast Missed Consensus Estimates Medifast (MED) reported a loss of $0.21 per share on revenue of $89.41 million for the third quarter ended September 2025. The consensus estimate was a loss of $0.01 per share on revenue of $87.66 million. The company missed consensus estimates by 2,000.00% while revenue fell 36.21% compared to the same quarter a year ago.
The company said it expects a fourth quarter loss of $1.25 to $0.70 per share on revenue of $65.0 million to $80.0 million. The current consensus estimate is a loss of $0.45 per share on revenue of $73.0 million for the quarter ending December 31, 2025.
Medifast Inc is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins.
|
 |
Advanced Micro Devices is Expected to Beat Estimates Advanced Micro Devices (AMD) is confirmed to report earnings on Tuesday, November 4, 2025 at approximately 4:15 PM ET. The consensus earnings estimate is $1.17 per share on revenue of $8.72 billion, respresenting 27.9% year-over-year revenue growth, and the Earnings Whisper ® number is $1.20 per share. Investors are 18.2% bullish going into the company's earnings release. Option traders are pricing in a 9.2% move on earnings and the stock has averaged a 6.4% move in recent quarters.
View Full Calendar
|
|
Sanmina Corporation (
Insperity, Inc. (
